THC-ETOH-I: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I

Sponsor
Yale University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02709954
Collaborator
(none)
40
1
4
81
0.5

Study Details

Study Description

Brief Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Condition or Disease Intervention/Treatment Phase
  • Drug: Active inhaled delta-9-THC
  • Drug: Placebo
  • Drug: Placebo
  • Drug: Active Oral Ethanol
Phase 1

Detailed Description

To study the effects of oral ethanol (a target BAC of ~0.04 g/dl; equivalent to consuming approximately 2 drinks over 1 hour) and vaporized THC (4 mg of THC dissolved in an ethanolic solution; equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint") on driving.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
Study Start Date :
Mar 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active THC and Placebo Ethanol

Drug: Active inhaled delta-9-THC
Low dose THC (~4 mg), dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes via a vaporizer.

Drug: Placebo
Control: Approximately 4 drinks of orange juice or ginger ale covered by a trace amount of ethanol on the surface, each administered over approximately 10 minutes.

Experimental: Active THC and Active Ethanol

Drug: Active inhaled delta-9-THC
Low dose THC (~4 mg), dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes via a vaporizer.

Drug: Active Oral Ethanol
0.4 g/kg ethanol in orange juice or ginger ale to reach a target BrAC of approximately 0.04%. This dose is equivalent to consuming approximately 2 standard drinks over 1 hour. Approximately 4 drinks, each administered over approximately 10 minutes.

Experimental: Placebo THC and Active Ethanol

Drug: Placebo
Control: No active THC. Administered over 20 minutes via a vaporizer. approximately 10 minutes.

Drug: Active Oral Ethanol
0.4 g/kg ethanol in orange juice or ginger ale to reach a target BrAC of approximately 0.04%. This dose is equivalent to consuming approximately 2 standard drinks over 1 hour. Approximately 4 drinks, each administered over approximately 10 minutes.

Placebo Comparator: Placebo THC and Placebo Ethanol

Drug: Placebo
Control: Approximately 4 drinks of orange juice or ginger ale covered by a trace amount of ethanol on the surface, each administered over approximately 10 minutes.

Drug: Placebo
Control: No active THC. Administered over 20 minutes via a vaporizer. approximately 10 minutes.

Outcome Measures

Primary Outcome Measures

  1. Road Tracking Error [baseline, +20, +50, +120, +180 mins after start of alcohol administration]

Secondary Outcome Measures

  1. Biphasic Alcohol Effects Scale (BAES) [baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration]

    A scale designed to assess the stimulant and sedative effects associated with alcohol intoxication.

  2. Visual Analog Scale (VAS) [baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration]

    Feeling states associated with alcohol and cannabis intoxication will be measured using this self-report scale of feeling states.

  3. Willingness to Drive Scale [baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration]

    Subjects will be asked to rate their willingness to drive at their current state in the context of various scenarios including willingness to drive from testing facility to a number of destinations that are different driving distances.

  4. Cognitive Test Battery [+40 mins after start of alcohol administration]

    Several computer tasks will be administered to assess alcohol and THC effects on driving related cognition, including: visual vigilance, visual motor function, attention and working memory, and processing speed.

  5. Number of Joints Scale [baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration]

    Subjects will be asked to rate the number of standard joints that they believe they have been administered.

  6. Number of Drinks Scale [baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration]

    Subjects will be asked to rate the number of standard drinks that they believe they have been administered.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males or females 21 to 55 years of age (extremes included).

  • Occasional current cannabis users.

  • Experience with drinking 2 or more standard drinks of alcohol at least once in lifetime.

  • Able to provide informed consent.

Exclusion Criteria:
  • Cannabis naïve.

  • Alcohol naïve.

  • Positive pregnancy screen

  • Hearing deficits.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Biological Studies Unit, VA Connecticut Healthcare System West Haven Connecticut United States 06516

Sponsors and Collaborators

  • Yale University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deepak C. D'Souza, Professor of Psychiatry, Yale University
ClinicalTrials.gov Identifier:
NCT02709954
Other Study ID Numbers:
  • 1501015208.A
First Posted:
Mar 16, 2016
Last Update Posted:
Feb 22, 2022
Last Verified:
Feb 1, 2022
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 22, 2022